Novastage Pharmaceuticals (Shenzhen), Ltd. was founded by Dr. Tang Jiansheng, an internationally renowned formulation expert, and Dr. Liao Shiping, a quality research expert.
We have the world's leading high-barrier formulation technology in the transdermal patch and oral film. We are developing the United States 505(b)(2) or China Class 2 new drugs with clinical advantages for the world.
We strive to demonstrate bioequivalence or clinical efficacy and safety endpoints by clinical trials through the 505(b)(2) application route. We will provide several blockbuster new drugs for patients in China, the United States and Europe within a few years to meet unmet medical needs. Our goal is to become a world’s leading pharmaceutical company in transdermal patch and oral film drug products.
Dr. Tang Jiansheng
Chief Executive Officer, Chief Scientific Officer, and Founder
He served as an executive in a world Fortune 500 company, established multiple transdermal and oral film technology platforms, and successfully led the development and commercialization of more than 10 transdermal patch and oral film drug products as well as a few decades of other dosage forms of drug products in the United States. He was the principal inventor of 35 US patents or patent applications, published 20 research articles in the world most prestigious journals, and won a US National Invention Award and an Outstanding Achievement Award of the Iowa State University Alumni Association. He received a doctorate degree from Iowa State University.
Dr. Liao Shiping
Vice president for quality management, co-founder
He worked in a world's top 500 fortune pharmaceutical company, served as a senior executive of a top 10 domestic pharmaceutical company, and co-developed more than 30 drug products in the United States. He received a doctorate in biochemistry from New York University and published a research article in the world's top journal "Science".
Our medical advisor is a famous cardiovascular physician in U.S.A.. He received his medical doctorate from the top medical school in the United States. He completed his residency in internal medicine and fellowship in cardiovascular disease at famous hospitals. He is a medical advisor for our 505(b)(2) projects.